Amicus Therapeutics, Inc. (FOLD) Ownership

$8.87

$0.03 (-0.34%)
Last update: 04:00 PM EST
Day's range
$8.7
Day's range
$8.98

Amicus Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 08/11/2025 29.41 M $168.51 M   1.23% 9.55%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2025 29.12 M $166.88 M   -0.26% 9.46%
BLACKROCK, INC. 08/12/2025 27.53 M $157.76 M   -1.05% 8.94%
AVORO CAPITAL ADVISORS LLC 08/14/2025 18.00 M $103.14 M   -12.20% 5.84%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 07/29/2025 14.64 M $83.90 M   -0.92% 4.75%
VESTAL POINT CAPITAL, LP 08/14/2025 11.90 M $68.19 M   178.36% 3.86%
STATE STREET CORP 08/14/2025 11.57 M $66.29 M   21.53% 3.76%
MACQUARIE GROUP LTD 08/14/2025 7.72 M $44.25 M   13.31% 2.51%
MILLENNIUM MANAGEMENT LLC 08/14/2025 7.42 M $42.53 M   120.92% 2.41%
PERCEPTIVE ADVISORS LLC 08/14/2025 7.41 M $42.48 M   -65.46% 2.41%
BANK OF AMERICA CORP /DE/ 08/14/2025 6.85 M $39.23 M   22.28% 2.22%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 6.71 M $38.43 M   -0.85% 2.18%
PALO ALTO INVESTORS LP 08/14/2025 5.61 M $32.15 M   -23.61% 1.82%
PICTET ASSET MANAGEMENT HOLDING SA 08/13/2025 3.91 M $22.78 M   139.99% 1.27%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 08/08/2025 3.73 M $21.35 M   13.74% 1.21%
NUVEEN, LLC 08/12/2025 3.63 M $20.81 M   3.11% 1.18%
ASSENAGON ASSET MANAGEMENT S.A. 07/11/2025 3.53 M $20.25 M   641.19% 1.15%
PROSIGHT MANAGEMENT, LP 08/14/2025 3.48 M $19.94 M   152.29% 1.13%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2025 3.47 M $19.87 M   223.86% 1.13%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2025 3.28 M $18.79 M   9.85% 1.06%
NORGES BANK 08/13/2025 3.24 M $18.54 M   100.00% 1.05%
NORTHERN TRUST CORP 08/13/2025 3.09 M $17.70 M   -8.45% 1.00%
RICE HALL JAMES & ASSOCIATES, LLC 08/11/2025 2.76 M $15.82 M   37.32% 0.90%
JANUS HENDERSON GROUP PLC 08/14/2025 2.75 M $15.78 M   -17.09% 0.89%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2025 2.55 M $14.60 M   2.29% 0.83%
BLACKSTONE INC. 08/14/2025 2.47 M $14.14 M   0.00% 0.80%
WOODLINE PARTNERS LP 08/14/2025 2.39 M $13.67 M   693.29% 0.77%
ORBIMED ADVISORS LLC 08/14/2025 2.29 M $13.10 M   0.00% 0.74%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 08/14/2025 2.22 M $12.74 M   368.16% 0.72%
HUDSON BAY CAPITAL MANAGEMENT LP 08/18/2025 2.21 M $12.68 M   -10.43% 0.72%
JPMORGAN CHASE & CO 08/12/2025 2.21 M $12.66 M   -54.84% 0.72%
CUBIST SYSTEMATIC STRATEGIES, LLC 08/14/2025 2.20 M $12.62 M   299.07% 0.72%
GRANITE INVESTMENT PARTNERS, LLC 08/13/2025 2.16 M $12.38 M   3.39% 0.70%
RENAISSANCE TECHNOLOGIES LLC 08/13/2025 2.01 M $11.54 M   28.91% 0.65%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2025 1.96 M $11.23 M   2.67% 0.64%
M&G PLC 08/08/2025 1.88 M $11.31 M   100.00% 0.61%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/07/2025 1.84 M $10.54 M   133.93% 0.60%
UBS GROUP AG 08/14/2025 1.69 M $9.70 M   26.66% 0.55%
VERITION FUND MANAGEMENT LLC 08/14/2025 1.52 M $8.68 M   438.84% 0.49%
PANAGORA ASSET MANAGEMENT INC 08/13/2025 1.44 M $8.27 M   -0.06% 0.47%
JUMP FINANCIAL, LLC 08/13/2025 1.41 M $8.06 M   246.30% 0.46%
ALGERT GLOBAL LLC 08/14/2025 1.35 M $7.76 M   65.06% 0.44%
INVESCO LTD. 08/13/2025 1.30 M $7.47 M   -51.00% 0.42%
DEUTSCHE BANK AG\ 08/12/2025 1.27 M $7.26 M   21.97% 0.41%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 08/14/2025 1.26 M $7.22 M   100.00% 0.41%
UBS ASSET MANAGEMENT AMERICAS INC 08/14/2025 1.26 M $7.20 M   17.09% 0.41%
BNP PARIBAS ARBITRAGE, SNC 08/14/2025 1.25 M $7.16 M   148.63% 0.41%
REDMILE GROUP, LLC 08/14/2025 1.19 M $6.81 M   -87.53% 0.39%
BARCLAYS PLC 08/14/2025 1.18 M $6.78 M   85.94% 0.38%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2025 1.05 M $6.00 M   -18.46% 0.34%

Amicus Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 404 institutional investors and hedge funds held shares of Amicus Therapeutics, Inc.. The most heavily invested institutionals were:

MASSACHUSETTS FINANCIAL SERVICES CO /MA/: 3.71 M

RICE HALL JAMES & ASSOCIATES, LLC: 3.43 M

Assenagon Asset Management S.A.: 1.85 M

Stephens Investment Management Group LLC: 1.26 M

PEREGRINE CAPITAL MANAGEMENT LLC: 1.08 M

NORDEA INVESTMENT MANAGEMENT AB: 997,780

96.67% of Amicus Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 368.09 M shares in the last 24 months. This purchase volume represents approximately $3.26 B in transactions.